Tag Archives: Covid-19 vaccines adverse effects

VP of German Parliament calls for full investigation into covid “vaccine” injuries and deaths, by Ethan Huff

The investigation would mandate autopsies for anyone who dies within two weeks of a Covid vaccination. From Ethan Huff at naturalnews.com:

Image: VP of German Parliament calls for full investigation into covid “vaccine” injuries and deaths

(Natural News) Following the discovery that upwards of 30 percent of all deaths that he and his team have evaluated are linked to covid “vaccination,” Bundestag (German federal parliament) vice president Wolfgang Kubicki is calling for a full investigatory autopsy to be conducted on all deceased who died shortly after getting the needle.

All unexplained deaths that occur within 14 days post-injection need to be looked at with a fine-toothed comb, Kubicki argues. He wants all such cases to also be automatically registered as a suspected covid jab-related case with the Paul Ehrlich Institute (PEI).

Investigating a “link between vaccination, myocarditis, and death is imperative,” the Free Democratic Party (FDP) politician said.

In a speech, Kubicki referenced a recently published study by Peter Schirmacher, the chief pathologist at the Heidelberg University Clinic. That study, mentioned earlier, found that at least 30 percent of all deaths are now occurring not long after the deceased got “vaccinated” for covid.

“We are talking about a relevant number that makes it necessary to approach this problem systematically,” Kubicki said, adding that health authorities need to “regularly” conduct autopsies on all people who die within two weeks of injection.

“That also makes sense because the conditional approval of these vaccines took place under enormous time pressure,” he added. (Related: Earlier this year, German Dr. Sonja Reitz pegged covid jabs as the cause of her country’s “excess death” problem.)

Continue reading→

Pfizer & Moderna Investors Run for the Exits, by Justus R. Hope

Is Wall Street beginning to smell a rat? Like, perhaps, that Covid vaccines are responsible for far more deaths and debilitating illnesses than anyone wants to admit, and that perhaps the manufacturers concealed data that would have raised red flags? From Justus R. Hope at thedesertreview.com:

Wall Street investors are dumping their Moderna and Pfizer stock faster than the world can drop the mandates. Moderna is down 70 percent from its high, while Pfizer is off 19 percent. Former Blackrock Executive and investment adviser Edward Dowd calls for Moderna to go to zero and Pfizer to end under ten dollars per share.

How is this possible given that Pfizer now enjoys record earnings per share and a market capitalization of some $270 billion, making it the 29th largest corporation globally? With nothing but profits in sight for the Pharmaceutical giant, what could be the problem?

After all, in December, a Forbes’ headline read, “The Vaccine Maker Can Dominate The Covid Market For Years to Come, Wells Fargo Predicts.” In addition to the enormously profitable mRNA vaccines, Pfizer is rolling out potent antivirals like Paxlovid, which could earn $22 billion in 2022.

https://www.forbes.com/sites/sergeiklebnikov/2021/12/09/this-vaccine-maker-can-dominate-the-covid-market-for-years-to-come-wells-fargo-predicts/

Compared to the $81 billion in 2021 revenue, the earnings from the vaccines and the antivirals could top $102 billion for 2022, which is music to shareholders’ ears. However some are hearing shrieks, and these happen to be Wall Street’s finest, the smart money that beats the rest of the herd to the exits like clockwork.

These sophisticated investors make it their business to not go with the conventional wisdom but to do their own research, which often pays spectacular dividends.

Edward Dowd is one such investor. He saw the dot com bubble ready to burst and acted accordingly. But, unfortunately, other not-so-savvy investors later saw their dot com heavy portfolios collapse as the NASDAQ Composite Index lost 40% of its value in 2000.

Dowd, a graduate of Notre Dame University and former Portfolio Manager at Blackrock, grew his fund from $2 billion to $14 billion and commanded the respect of his investment community peers.

Today, after semi-retiring to the shores of South Maui, he remains a voice of stock market wisdom that many hedge funds continue to rely upon. LinkedIn lists him as a Consultant to Founder & Partner of Symphonic Capital, LLC.

Continue reading→